It thus seems likely that these two mutations (the c.1114delG mutation in the TYR gene and the c.1426A>G mutation in the OCA2 gene) may be responsible for partial clinical manifestations of OCA in heterozygous carriers. Here, OCA2 is linked to oculocutaneous albinism.